logo

Voyager Therapeutics (VYGR)



Trade VYGR now with
  Date
  Headline
3/22/2022 7:20:07 AM Voyager Therapeutics Appoints Alfred Sandrock As CEO
3/8/2022 3:20:37 AM Voyager Therapeutics Announces License Option Deal With Novartis For TRACER AAV Capsids For Gene Therapy Programs
10/6/2021 7:23:29 AM Voyager Therapeutics Announces Licensing Agreement With Pfizer
5/27/2021 8:12:57 AM Voyager Digital Announces Initiation Into The Blockchain Association
6/18/2019 6:29:23 AM Wedbush Is Cutting Voyager Therapeutics (VYGR) FY19 Estimate To -3.59 From -3.19
6/18/2019 6:29:11 AM Wedbush Is Cutting Voyager Therapeutics (VYGR) Q4 19 Estimate To -1.07 From -0.80
6/18/2019 6:28:51 AM Wedbush Is Lowering Voyager Therapeutics (VYGR) Q2 19 Estimate To -0.91 From -0.78
6/18/2019 6:28:19 AM Wedbush Reiterates Voyager Therapeutics (VYGR) At Outperform With $36 Up From $27 Price Target
2/28/2019 8:42:30 AM Wedbush Is Lowering Voyager Therapeutics (VYGR) FY19 Rev. Estimate To 20.0 M From 125.5 M
2/28/2019 8:42:19 AM Wedbush Is Lowering Voyager Therapeutics (VYGR) Q4 19 Rev. Estimate To 5.0 M From 31.4 M
2/28/2019 8:42:13 AM Wedbush Is Lowering Voyager Therapeutics (VYGR) Q3 19 Rev. Estimate To 5.0 M From 31.4 M
2/28/2019 8:42:08 AM Wedbush Is Lowering Voyager Therapeutics (VYGR) Q2 19 Rev. Estimate To 5.0 M From 31.4 M
2/28/2019 8:41:59 AM Wedbush Is Lowering Voyager Therapeutics (VYGR) Q1 19 Rev. Estimate To 5.0 M From 31.4 M